Kato, Koji <br/><br/>
Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.  [electronic resource] 

 -  Pediatric blood & cancer  Apr 2014 
 - 712-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.24922  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation<br/>Busulfan--administration & dosage<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cytarabine--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Graft vs Host Disease--mortality<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Leukemia, Myeloid, Acute--mortality<br/>Male<br/>Melphalan--administration & dosage<br/>Neoplasm Recurrence, Local--mortality<br/>Postoperative Complications<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--mortality<br/>Prognosis<br/>Remission Induction<br/>Survival Rate<br/>Transplantation Conditioning<br/>Transplantation, Homologous<br/>Vidarabine--administration & dosage<br/>Whole-Body Irradiation